Skip to main content
Caplight Logo









Nemedio

Nemedio

Private
Brooklyn, New YorkHealthcare & Life Scienceshttps://nemedio.com/

Last Round

Series A

Extension

Jun 12, 2023

Total Funding Raised

$2.01M

Company Overview

Nemedio is a healthcare technology company that provides software, hardware, and quality management platform to accelerate the development of medical devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Quality Management, Vertical SaaS, Compliance & Risk

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

medical device developmentquality management systemQMSFDA compliancemedtechregulatory compliancemedical device softwarehardware prototypingvertical SaaSdesign controlrisk managementeQMSmedical device startupengineering support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nemedio Comparables

Compare Nemedio with similar companies based on industry and business-model similarity.

Nemedio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sierra Labs
83%
Greenlight Guru
82%
Matrix One
77%

Nemedio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 12, 2023
SeedFeb 25, 2022
DebtApr 28, 2020
SeedJun 18, 2019
Pre SeedMay 31, 2018
Grant
Oct 10, 2017

Nemedio Investors

Notable investors and investment history

Nemedio investors
InvestorRounds
Charge VenturesSeed, Pre Seed
Eniac VenturesSeed
Notation CapitalSeed, Pre Seed
Supernode VenturesSeed, Pre Seed
Bowery CapitalSeed
Downtown Brooklyn PartnershipGrant
Neu Venture CapitalSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 31, 2018

    $1M raised from Neu Venture Capital, Notation Capital, and others.

Nemedio Filings

Explore SEC and related filing metadata, where available.

Nemedio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nemedio's valuation, stock price, and market status.

Is Nemedio a public or private company?

Nemedio is a private company.

What is the current stock price of Nemedio?

Nemedio is a private company with no public stock price. No recent secondary market data is available.

How much is Nemedio worth (valuation)?

Valuation information for Nemedio is not publicly available.

Can I buy Nemedio stock?

Nemedio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nemedio's last funding round?

Nemedio's most recent funding round was Series A Extension on June 12, 2023.

Who are the main investors in Nemedio?

Key investors in Nemedio include Charge Ventures, Notation Capital, Bowery Capital, Downtown Brooklyn Partnership, Neu Venture Capital.

Will Nemedio IPO soon?

No public IPO plans have been announced for Nemedio.

How can I track Nemedio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nemedio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrooklyn, New York
Employee Range1
Year Founded2017
Last FundingJun 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?